[1] Force UPST. Screening for osteoporosis: us preventive services task force recommendation statement. Ann Int Med. 2011;154:356.[2] Rachner TD, Khosla S, Hofbauer LC. Osteoporosis: now and the future. Lancet. 2011;377:1276-1287.[3] Jiang C, Chen J, Liu F, et al. Chronic mountain sickness in chinese han males who migrated to the qinghai-tibetan plateau: application and evaluation of diagnostic criteria for chronic mountain sickness. BMC Public Health. 2014;14:701.[4] Maes C, Carmeliet G, Schipani E. Hypoxia-driven pathways in bone development, regeneration and disease. Nat Rev Rheumatol. 2012;8:358-366.[5] Terrizzi AR, Fernandez-Solari J, Lee CM, et al. Deleterious effect of chronic continuous hypoxia on oral health. Arch Oral Biol. 2016;72:1-7. [6] Li Q, Liu R, Zhao J, et al. N-methyl pyrrolidone (NMP) ameliorates the hypoxia-reduced osteoblast differentiation via inhibiting the NF-κB signaling. J Toxicol Sci. 2016;41: 701-709. [7] Huang J, Peng J, Cao G, et al. Hypoxia-induced MicroRNA-429 Promotes Differentiation of MC3T3-E1 osteoblastic cells by mediating ZFPM2 expression. Cell Physiol Biochem. 2016;39:1177-1186. [8] Kim JH, Yoon SM, Song SU, et al. Hypoxia suppresses spontaneous mineralization and osteogenic differentiation of mesenchymal stem cells via IGFBP3 up-regulation. Int J Mol Sci. 2016;17:E1389. [9] Wang G, Wang J, Sun D, et al. Short-term hypoxia accelerates bone loss in ovariectomized rats by suppressing osteoblastogenesis but enhancing osteoclastogenesis. Med Sci Monit. 2016;22:2962-2971.[10] Gu Q, Gu Y, Shi Q, et al. Hypoxia promotes osteogenesis of human placental-derived mesenchymal stem cells. Tohoku J Exp Med. 2016;239:287-296. [11] Peng J, Hui K, Hao C, et al. Low bone turnover and reduced angiogenesis in streptozotocin-induced osteoporotic mice. Connect Tissue Res. 2016;57:277-289. [12] Tournis S, Dede AD, Savvidis C, et al. Effects of teriparatide retreatment in a patient with β-thalassemia major. Transfusion. 2016;55:2905-2910. [13] Li W, Wang K, Liu Z, et al. HIF-1α change in serum and callus during fracture healing in ovariectomized mice. Int J Clin Exp Pathol. 2015;8:117-126. [14] Liu X, Tu Y, Zhang L, et al. Prolyl hydroxylase inhibitors protect from the bone loss in ovariectomy rats by increasing bone vascularity. Cell Biochem Biophys. 2014;69:141-149. [15] Miller RG, Segal JB, Ashar BH, et al. High prevalence and correlates of low bone mineral density in young adults with sickle cell disease. Am J Hematol. 2006; 81:236-241.[16] Wagegg M, Gaber T, Lohanatha FL, et al. Hypoxia promotes osteogenesis but suppresses adipogenesis of human mesenchymal stromal cells in a hypoxia-inducible factor-1 dependent manner. PLoS One. 2012;7:e46483.[17] Li DC, Liu ZH, Shi SH, et al. A retrospective literature study of osteoporosis incidence based on -2.5SD criteria in mainland China. 2015;22:1-8.[18] Li S, Li J, Dai W, et al. Genistein suppresses aerobic glycolysis and induces hepatocellular carcinoma cell death. Br J Cancer. 2017. doi: 10.1038/bjc.2017.323.[19] Guo X, Chen Y, Fang W, et al. Metastasis associated protein 1 correlates with Hypoxia inducible-factor 1 alpha expression and lymphangiogenesis in esophageal cancer. Thorac Cancer. 2013;4:312-317. [20] Shrestha P, Davis DA, Veeranna RP, et al. Hypoxia-inducible factor-1 alpha as a therapeutic target for primary effusion lymphoma. PLoS Pathog. 2017. doi: 10.1371/journal.ppat.1006628.[21] Kling L, Benck U, Breedijk A, et al. Changes in CD73, CD39 and CD26 expression on T-lymphocytes of ANCA-associated vasculitis patients suggest impairment in adenosine generation and turn-over. Sci Rep. 2017. doi: 10.1038/s41598-017-12011-4.[22] Hall B, Zebrowska A, Kaminski T, et al. Effects of hypoxia during continuous and intermittent exercise on glycaemic control and selected markers of vascular function in type 1 diabetes. Exp Clin Endocrinol Diabetes. 2017. doi: 10.1055/s-0043-110482. [23] Wang L, Jin Z, Wang J, et al. Detrimental effect of Hypoxia-inducible factor-1α-induced autophagy on multiterritory perforator flap survival in rats. Sci Rep. 2017. doi: 10.1038/s41598-017-12034-x.[24] Bentkowski W, Ku?niewski M, Fedak D, et al. Undercarboxylated osteocalcin (Glu-OC) bone metabolism and vascular calcification in hemodialyzed patients. Przegl Lek. 2013;70:703-706. [25] Kim KJ, Kim KM, Park KH, et al. Aortic calcification and bone metabolism: the relationship between aortic calcification, BMD, vertebral fracture, 25-hydroxyvitamin D, and osteocalcin. Calcif Tissue Int. 2012;91:370-378. [26] Wang R, Zhang S, Jiang Z, et al. Bone metabolism markers: Indicators of loading dose intravenous ibandronate treatment for bone metastases from breast cancer. Clin Exp Pharmacol Physiol. 2017. doi: 10.1111/1440-1681.12673.[27] Yuan TL, Chen J, Tong YL, et al. Serum heme oxygenase-1 and BMP-7 are potential biomarkers for bone metabolism in patients with rheumatoid arthritis and ankylosing spondylitis. Biomed Res Int. 2016. doi: 10.1155/2016/7870925.[28] Li DC. The correlation among serum hypoxia-inducible factor-1α, hypoxia-inducible factor 2α, vascular endothelial growth factor, and bone mineral density and bone metabolism in senior men with osteoporosis in Qinghai-Tibetan high plateau. Zhongguo Guzhi Shusong Zazhi. 2015;21: 1328-1332.[29] Zhang H, Lei C, Zhang TY. Transcutaneous electri¬cal acupoint stimulation with different acupoint combinations on opioid consumption in patients undergoing off-pump coronary artery bypass grafting: study protocol for a randomized double-blind controlled trial. Clin Transl Degener Dis. 2016;1: 17-24.[30] Wang Y. Chinese medicine packet plus wax therapy for periarthritis of the shoulder: study protocol for a multi-center randomized controlled trial. Clin Transl Degener Dis. 2016;1: 25-31.[31] Ma N, Peng J, Guo QY. Local administration of enriched mononuclear cells, platelets and zoledronic acid for preventing collapse of the femoral head in the early stage of osteonecrosis: study protocol for a prospective randomized parallel-controlled clinical trial. Clin Transl Degener Dis. 2016;1:32-37 |